Yi Hsiung Chen
Directeur/Membre du Conseil chez HO TUNG CHEMICAL CORP.
Profil
Yi Hsiung Chen is currently the Chairman & General Manager at Vita Genomics, Inc. He also holds the position of Chairman at Chia-Ho Co., Ltd., Chi-Chi Co. Ltd., Chia He Investment Co. Ltd., Merit Ocean Biotech, Inc., Ho Tung Chemical Corp., CytoPharm, Inc., Pharmigene, Inc., Ya Tung Investment Co. Ltd., Hakers Enterprise Co. Ltd., Eden Biologics, Inc., Yurun Merit Biotech (Lianyungang) Co. Ltd., Yuan He Biotech Co. Ltd., and Chenergy Co. Ltd.
Previously, he served as Chairman, Investor Relations Contact & Spokesman at Merit Biotech, Inc. He was also a Director at PE Corp.
(New York), Shanghai GeneCore BioTechnologies Co., Ltd., Development Center for Biotechnology, and Polaris Group.
Additionally, he worked as a Senior Scientist at Genentech, Inc. from 1980 to 1992 and as a Principal at Celera Group.
He was a Member at the National Institutes of Health.
Dr. Chen obtained a doctorate degree from Kent State University (Ohio) and an undergraduate degree from National Taiwan University.
Postes actifs de Yi Hsiung Chen
| Sociétés | Poste | Début |
|---|---|---|
| HAKERS ENTERPRISE CO., LTD. | Directeur/Membre du Conseil | 23/06/2020 |
| JHL BIOTECH, INC. | Directeur/Membre du Conseil | 14/05/2015 |
| HO TUNG CHEMICAL CORP. | Directeur/Membre du Conseil | 01/08/2008 |
| PHARMIGENE, INC. | Directeur/Membre du Conseil | 24/11/2020 |
| Chia-Ho Co., Ltd. | Président | - |
| Yuan He Biotech Co. Ltd. | Directeur/Membre du Conseil | - |
| Chenergy Co. Ltd. | Directeur/Membre du Conseil | - |
| Yurun Merit Biotech (Lianyungang) Co. Ltd. | Directeur/Membre du Conseil | - |
Chia He Investment Co. Ltd.
 Chia He Investment Co. Ltd. Financial ConglomeratesFinance Chia He Investment Co. Ltd. operates as an investment holding Taiwanese company. | Président | - |
| ░░ ░░░░ ░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░ ░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░ | - |
Anciens postes connus de Yi Hsiung Chen
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░ ░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░░░░░░ ░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
| ░░ ░░░░░ ░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Formation de Yi Hsiung Chen
| Kent State University (Ohio) | Doctorate Degree |
| National Taiwan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| HAKERS ENTERPRISE CO., LTD. | Consumer Non-Durables |
| MERIT BIOTECH INC | Health Technology |
| POLARIS GROUP | Health Technology |
| HO TUNG CHEMICAL CORP. | Process Industries |
| PHARMIGENE, INC. | Health Technology |
| Entreprise privées | 17 |
|---|---|
Celera Group
 Celera Group Pharmaceuticals: MajorHealth Technology Celera Group provides molecular diagnostics using proprietary genomics and proteomics discovery platforms to identify and validate novel diagnostic markers and to develop diagnostic products based on these markers. These diagnostic products are used to predict disease risk and optimize therapy selection, monitoring and patient outcome. The company was founded in May, 1998 and is located in Rockville, MD | Health Technology |
Chia He Investment Co. Ltd.
Chia He Investment Co. Ltd. Financial ConglomeratesFinance Chia He Investment Co. Ltd. operates as an investment holding Taiwanese company. | Finance |
National Institutes of Health
 National Institutes of Health General GovernmentGovernment National Institutes Of Health conducts & supports peer-reviewed medical research and science. The firm's scientists & researchers investigate on different ways to prevent diseases as well as the causes, treatments and cures for common and rare diseases. The company was founded in 1887 and is headquartered in Bethesda, MD. | Government |
Development Center for Biotechnology
 Development Center for Biotechnology Medical/Nursing ServicesHealth Services The Development Center for Biotechnology of Taiwan is a nonprofit organization co-sponsored by government grants and private donations. It focuses on biotechnology and pharmaceutical industry. The company was founded in 1984 and is headquartered in Taipei, Taiwan. | Health Services |
CytoPharm, Inc.
 CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |
Vita Genomics, Inc.
 Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |
| Chi-Chi Co. Ltd. | |
| Merit Ocean Biotech, Inc. | |
| Ya Tung Investment Co. Ltd. | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
| Chia-Ho Co., Ltd. | |
Shanghai GeneCore BioTechnologies Co., Ltd.
 Shanghai GeneCore BioTechnologies Co., Ltd. BiotechnologyHealth Technology Part of Quest Diagnostics, Inc., Shanghai GeneCore BioTechnologies Co., Ltd. engages in nucleotide synthesis, DNA sequencing, bioinformatics analysis, and mutation detection. The private company is based in Shanghai, China. | Health Technology |
| PE Corp. (New York) | Health Technology |
| Yurun Merit Biotech (Lianyungang) Co. Ltd. | |
Eden Biologics, Inc.
 Eden Biologics, Inc. Pharmaceuticals: MajorHealth Technology Eden Biologics, Inc. is engaged in the manufacture and sale of bio-pharmaceuticals products. It offers cell line cloning, antibody cloning, monoclonal antibody, cell line development, master and working cell banks, cell culture process development, purification process development, formulation development, and analytical assays. The company was founded on June 14, 2012 and is headquartered in Zhupei, Taiwan. | Health Technology |
| Chenergy Co. Ltd. | |
| Yuan He Biotech Co. Ltd. |
